Answers are grounded in this paper and cite their sources.
Observational analysis reveals NCEH1 accelerates breast cancer progression through NRP1 modulation, suggesting its role as a novel therapeutic target.
Our findings demonstrate that NCEH1 accelerates breast cancer progression by modulating NRP1 and activating the TNF-α/NF-κB signalling pathway. Collectively, NCEH1 represents a potential novel biomarker and therapeutic target for breast cancer.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: